TY - JOUR
T1 - Sleep quality among breast and prostate cancer patients
T2 - A comparison between subjective and objective measurements
AU - Barsasella, Diana
AU - Syed-Abdul, Shabbir
AU - Malwade, Shwetambara
AU - Kuo, Terry B.J.
AU - Chien, Ming Jen
AU - Núñez-Benjumea, Francisco J.
AU - Lai, Gi Ming
AU - Kao, Ruey Ho
AU - Shih, Hung Jen
AU - Wen, Yu Ching
AU - Li, Yu Chuan
AU - Carrascosa, Iván Palomares
AU - Bai, Kuan Jen
N1 - Funding Information:
This work was supported in part by the Ministry of Science and Technology, Taiwan (grant numbers 108-2221-E-038-013 and 110-2923-E-038-001-MY3); the Taipei Medical University, Taiwan (grant number 108-3805-009-110); the Ministry of Education, Taiwan (grant number 108-6604-002-400); and Wanfang hospital, Taiwan (grant number 106TMU-WFH-01-4).We are thankful to the Ministry of Science and Technology (MOST) and the Taipei Medical University for providing the funding to carry out this research work. We are thankful to the Taipei Municipal Wanfang Hospital, which aided in the data collection of cancer patients. We also acknowledge. Luis Fernandez-Luque from Salumedia Labs SLU, Spain, for this collaboration and for enabling a student exchange with partial financial support to facilitate this research work. We are also grateful to the members of the CATCH project [57] and Francisco Monteiro-Guerra for providing feedback on the conceptual versions of this article. In addition, we also acknowledge the support provided in part by Higher Education Sprout Project, Ministry of Education to the Headquarters of University Advancement at National Cheng Kung University (NCKU).
Funding Information:
Funding: This work was supported in part by the Ministry of Science and Technology, Taiwan (grant numbers 108-2221-E-038-013 and 110-2923-E-038-001-MY3); the Taipei Medical University, Taiwan (grant number 108-3805-009-110); the Ministry of Education, Taiwan (grant number 108-6604-002-400); and Wanfang hospital, Taiwan (grant number 106TMU-WFH-01-4).
Funding Information:
Acknowledgments: We are thankful to the Ministry of Science and Technology (MOST) and the Taipei Medical University for providing the funding to carry out this research work. We are thankful to the Taipei Municipal Wanfang Hospital, which aided in the data collection of cancer patients. We also acknowledge. Luis Fernandez-Luque from Salumedia Labs SLU, Spain, for this collaboration and for enabling a student exchange with partial financial support to facilitate this research work. We are also grateful to the members of the CATCH project [57] and Francisco Monteiro-Guerra for providing feedback on the conceptual versions of this article. In addition, we also acknowledge the support provided in part by Higher Education Sprout Project, Ministry of Education to the Headquarters of University Advancement at National Cheng Kung University (NCKU).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/7
Y1 - 2021/7
N2 - Breast and prostate cancer patients may experience physical and psychological distress, and a possible decrease in sleep quality. Subjective and objective methods measure different aspects of sleep quality. Our study attempted to determine differences between objective and subjective measurements of sleep quality using bivariate and Pearson’s correlation data analysis. Forty breast (n = 20) and prostate (n = 20) cancer patients were recruited in this observational study. Participants were given an actigraphy device (ACT) and asked to continuously wear it for seven consecutive days, for objective data collection. Following this period, they filled out the Pittsburgh Sleep Quality Index Questionnaire (PSQI) to collect subjective data on sleep quality. The correlation results showed that, for breast cancer patients, PSQI sleep duration was moderately correlated with ACT total sleeping time (TST) (r = −0.534, p < 0.05), and PSQI daytime dysfunction was related to ACT efficiency (r = 0.521, p < 0.05). For prostate cancer patients, PSQI sleep disturbances were related to ACT TST (r = 0.626, p < 0.05). Both objective and subjective measurements are important in validating and determining details of sleep quality, with combined results being more insightful, and can also help in personalized care to further improve quality of life among cancer patients.
AB - Breast and prostate cancer patients may experience physical and psychological distress, and a possible decrease in sleep quality. Subjective and objective methods measure different aspects of sleep quality. Our study attempted to determine differences between objective and subjective measurements of sleep quality using bivariate and Pearson’s correlation data analysis. Forty breast (n = 20) and prostate (n = 20) cancer patients were recruited in this observational study. Participants were given an actigraphy device (ACT) and asked to continuously wear it for seven consecutive days, for objective data collection. Following this period, they filled out the Pittsburgh Sleep Quality Index Questionnaire (PSQI) to collect subjective data on sleep quality. The correlation results showed that, for breast cancer patients, PSQI sleep duration was moderately correlated with ACT total sleeping time (TST) (r = −0.534, p < 0.05), and PSQI daytime dysfunction was related to ACT efficiency (r = 0.521, p < 0.05). For prostate cancer patients, PSQI sleep disturbances were related to ACT TST (r = 0.626, p < 0.05). Both objective and subjective measurements are important in validating and determining details of sleep quality, with combined results being more insightful, and can also help in personalized care to further improve quality of life among cancer patients.
KW - Actigraphy device
KW - Breast cancer
KW - Medical aid systems
KW - Medical data analysis
KW - Prostate cancer
KW - PSQI
KW - Sleep quality
KW - Wearable sensors
UR - http://www.scopus.com/inward/record.url?scp=85109370743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109370743&partnerID=8YFLogxK
U2 - 10.3390/healthcare9070785
DO - 10.3390/healthcare9070785
M3 - Article
AN - SCOPUS:85109370743
SN - 2227-9032
VL - 9
JO - Healthcare (Switzerland)
JF - Healthcare (Switzerland)
IS - 7
M1 - 785
ER -
